SciSparc (SPRC) announced that the stockholders of N2OFF (NITO) voted on and approved, among other things, the proposed acquisition of SciSparc’s majority owned subsidiary, MitoCareX Bio Ltd.. This important milestone, achieved at N2OFF’s special meeting of stockholders held on September 25, clears a key path for the completion of the acquisition, which would result in MitoCareX becoming a wholly owned subsidiary of N2OFF.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SPRC: